Search

Your search keyword '"Cuccia, Claudio"' showing total 161 results

Search Constraints

Start Over You searched for: Author "Cuccia, Claudio" Remove constraint Author: "Cuccia, Claudio"
161 results on '"Cuccia, Claudio"'

Search Results

1. Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2

3. Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial

4. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

5. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

7. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

11. Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology

13. 640 QRS INDEX TO PREDICT CARDIAC RESYNCHRONIZATION THERAPY RESPONSE: A TRICENTRIC STUDY

17. Acute Coronary Syndromes and SARS-CoV-2 Infection: Results From an Observational Multicenter Registry During the Second Pandemic Spread in Lombardy

18. Transcatheter Aortic Valve Replacement With Self-Expanding ACURATE neo2

19. Acute coronary syndromes during the first and the second wave of COVID-19

23. Transcatheter Aortic Valve Replacement With Self-Expanding ACURATE neo2: Postprocedural Hemodynamic and Short-Term Clinical Outcomes

25. Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial

28. Major cardiovascular events in patients with Coronavirus Disease 2019: Experience of a cardiovascular department of Northern Italy

29. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

30. Management of acute coronary syndromes during the COVID-19 outbreak in Lombardy: The “macro-hub” experience

32. Coronary angiographic findings in patients with clinical unstable angina according to cardiac troponin I and T concentrations in serum; a comparative analysis

33. Centralization of the ST elevation myocardial infarction care network in the Lombardy region during the COVID-19 outbreak

37. Major Cardiovascular Events in Patients with COVID-19: Experience of a Cardiovascular Department in the Lombardia Region of Northern Italy

38. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

39. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

40. Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

43. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

44. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

45. Coronary stents and vascular response to implantation: literature review

46. ANMCO Position Paper: the use of non-vitamin K dependent new oral anticoagulant(s) in pulmonary embolism therapy and prevention

47. PDF-ECG in clinical practice: A model for long-term preservation of digital 12-lead ECG data.

Catalog

Books, media, physical & digital resources